{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:17:08Z","timestamp":1791404228466,"version":"4.3.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MRNO2995X\/1"],"award-info":[{"award-number":["MRNO2995X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000351","name":"British Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.chest.2021.11.014","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T20:06:24Z","timestamp":1637784384000},"page":"1180-1191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease"],"prefix":"10.1016","volume":"161","author":[{"given":"Rebecca C.","family":"Hull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alun K.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly R.","family":"Keir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huw","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.C.","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam F.","family":"Moffatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Loebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib1","doi-asserted-by":"crossref","first-page":"1900250","DOI":"10.1183\/13993003.00250-2019","article-title":"Non-tuberculous mycobacterial pulmonary disease","volume":"54","author":"Cowman","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib2","doi-asserted-by":"crossref","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/09031936.00074207","article-title":"Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings","volume":"32","author":"Kuroishi","year":"2008","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2021.11.014_bib4","doi-asserted-by":"crossref","first-page":"1602109","DOI":"10.1183\/13993003.02109-2016","article-title":"Burden of non-tuberculous mycobacterial pulmonary disease in Germany","volume":"49","author":"Diel","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib5","doi-asserted-by":"crossref","first-page":"1900798","DOI":"10.1183\/13993003.00798-2019","article-title":"Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study","volume":"55","author":"Jhun","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib6","doi-asserted-by":"crossref","first-page":"1901300","DOI":"10.1183\/13993003.01300-2019","article-title":"Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease","volume":"55","author":"Henkle","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib7","doi-asserted-by":"crossref","first-page":"1900795","DOI":"10.1183\/13993003.00795-2019","article-title":"Same meat, different gravy: ignore the new names of mycobacteria","volume":"54","author":"Tortoli","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2021.11.014_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/QCO.0b013e328336ead6","article-title":"Nontuberculous mycobacterial lung disease","volume":"23","author":"Griffith","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"2 pt 2","key":"10.1016\/j.chest.2021.11.014_bib9","first-page":"S1","article-title":"Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association","volume":"156","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2021.11.014_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pulmoe.2017.12.005","article-title":"Non-tuberculous mycobacterial pulmonary infections","volume":"24","author":"Chalmers","year":"2018","journal-title":"Pulmonology"},{"issue":"7","key":"10.1016\/j.chest.2021.11.014_bib11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/cid\/cix517","article-title":"Treatment outcomes of Mycobacterium avium complex lung disease: a systematic review and meta-analysis","volume":"65","author":"Kwak","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib12","doi-asserted-by":"crossref","first-page":"1801991","DOI":"10.1183\/13993003.01991-2018","article-title":"Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis","volume":"54","author":"Kwak","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.chest.2017.04.166","article-title":"Microbiological and clinical outcomes of treating non-Mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis","volume":"152","author":"Diel","year":"2017","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.chest.2021.11.014_bib14","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2021.11.014_bib15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3390\/ijms17111913","article-title":"Characterizing non-tuberculous Mycobacteria infection in bronchiectasis","volume":"17","author":"Faverio","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.chest.2021.11.014_bib16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaci.2020.02.040","article-title":"The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease","volume":"147","author":"Dicker","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.chest.2021.11.014_bib18","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2021.11.014_bib19","doi-asserted-by":"crossref","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","article-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.chest.2021.11.014_bib20","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","article-title":"The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study","volume":"9","author":"Dicker","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2021.11.014_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1164\/rccm.200703-409OC","article-title":"Sputum proteomics in inflammatory and suppurative respiratory diseases","volume":"178","author":"Gray","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.11.014_bib22","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2147\/COPD.S75978","article-title":"Protein networks in induced sputum from smokers and COPD patients","volume":"10","author":"Baraniuk","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"10.1016\/j.chest.2021.11.014_bib23","doi-asserted-by":"crossref","first-page":"2101840","DOI":"10.1183\/13993003.01840-2021","article-title":"SPLUNC1 is a novel marker of disease severity and airway infection in bronchiectasis","volume":"58","author":"Keir","year":"2021","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2021.11.014_bib24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.200305-648OC","article-title":"Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease","volume":"170","author":"Patel","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2021.11.014_bib25","doi-asserted-by":"crossref","first-page":"2000507","DOI":"10.1183\/13993003.00507-2020","article-title":"SPLUNC1: a novel marker of cystic fibrosis exacerbations","volume":"58","author":"Khanal","year":"2021","journal-title":"Eur Respir J"},{"issue":"153","key":"10.1016\/j.chest.2021.11.014_bib26","doi-asserted-by":"crossref","first-page":"190048","DOI":"10.1183\/16000617.0048-2019","article-title":"The microbiome in bronchiectasis","volume":"28","author":"Richardson","year":"2019","journal-title":"Eur Respir Rev"},{"issue":"2","key":"10.1016\/j.chest.2021.11.014_bib27","doi-asserted-by":"crossref","first-page":"1801711","DOI":"10.1183\/13993003.01711-2018","article-title":"Characterising the respiratory microbiome","volume":"53","author":"Watson","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2021.11.014_bib28","first-page":"1309746","article-title":"Airway epithelium dysfunction in cystic fibrosis and COPD","volume":"2018","author":"De Rose","year":"2018","journal-title":"Mediators Inflamm"},{"issue":"D1","key":"10.1016\/j.chest.2021.11.014_bib29","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.chest.2021.11.014_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/ph12020075","article-title":"Iron supplementation therapy, a friend and foe of mycobacterial infections?","volume":"12","author":"Agoro","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"10.1016\/j.chest.2021.11.014_bib31","doi-asserted-by":"crossref","first-page":"e01902","DOI":"10.1128\/mBio.01092-17","article-title":"The capacity of Mycobacterium tuberculosis to survive iron starvation might enable it to persist in iron-deprived microenvironments of human granulomas","volume":"8","author":"Kurthkoti","year":"2017","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.chest.2021.11.014_bib32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1165\/rcmb.2017-0230OC","article-title":"Whole-blood gene expression in pulmonary nontuberculous mycobacterial infection","volume":"58","author":"Cowman","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/resp.13886","article-title":"Serum Krebs von den Lungen-6 level in the disease progression and treatment of Mycobacterium avium complex lung disease","volume":"26","author":"Asakura","year":"2021","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.chest.2021.11.014_bib34","doi-asserted-by":"crossref","first-page":"1802058","DOI":"10.1183\/13993003.02058-2018","article-title":"Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.chest.2021.11.014_bib35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"22","key":"10.1016\/j.chest.2021.11.014_bib36","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib37","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1038\/s41598-020-60132-0","article-title":"miRNA expression profiles and potential as biomarkers in nontuberculous mycobacterial pulmonary disease","volume":"10","author":"Han","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.chest.2021.11.014_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201809-1651OC","article-title":"Airway bacterial load and inhaled antibiotic response in bronchiectasis","volume":"200","author":"Sibila","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.11.014_bib39","unstructured":"National Institutes of Health Clinical Center. The BRIDGE study - bronchiectasis research involving databases, genomics and endotyping (BRIDGE). NCT03791086. ClinicalTrials.gov. National Institutes of Health; 2019. Updated November 29, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03791086"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221044123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369221044123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:02:42Z","timestamp":1762124562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369221044123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0012369221044123"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.11.014","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sputum Proteomics in Nontuberculous Mycobacterial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}